| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.43 | 0.006 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.13 | 0.006 |